Search

everythinglearnresearchcommunity

for

Search:↓

Stress and hormones like progesterone can affect absence seizures, but their effects change with different life stages.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

The black orchid Brasiliorchis schunkeana produces chemicals that attract certain insects and have potential antimicrobial properties.

Personalized medicine is important for treating skin disorders, with new treatments and connections to hormones and genetics being explored.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Hair and nails can show hormone changes during puberty in dogs.

Diane® is an effective contraceptive that also helps treat acne and mild hair growth issues.

Hormone therapy might help improve women's appearance as they age.

Low estrogen compared to androgen may cause female hair loss.

SHBG may be a useful early indicator and treatment target for PCOS.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

Women of reproductive age with polycystic ovary syndrome often experience hair loss.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Oophorectomy lowers testosterone and estrogen levels in both premenopausal and postmenopausal women, with postmenopausal women still producing significant testosterone.

Dihydrotestosterone has a reduced effect on muscle-building in people with testicular feminization syndrome, especially after their gonads are removed.

Estrogen can temporarily slow down hair growth but this can be reversed.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

COVID-19 patients may experience temporary hair loss, mainly in women, which is likely reversible.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

The study found specific proteins that could mark different growth stages of cashmere goat hair and may help improve cashmere production.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Changing estrogen levels during menopause might affect genes related to body rhythms and cause increased hair loss.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

The conclusion is that proper signaling is crucial for hair growth and development, and errors can lead to cancer or hair loss.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.